Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Specnova LLC has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners and 2 art units, so each action follows a separate examination path.
PALLAY, MICHAEL B handles 1 pending matter and is the busiest examiner. Counsel should tailor each response to its assigned examiner while maintaining consistent explanations of the underlying pharmaceutical technology.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PALLAY, MICHAEL B | 1 | 55.8% | +33.8% |
| ALAM, AYAAN A | 1 | 38.8% | +36.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18885217 | POLYMER BEADLET COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE | PALLAY, MICHAEL B | — |
| 18329272 | NOVEL PROCESS | ALAM, AYAAN A | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18885217 | POLYMER BEADLET COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE | PALLAY, MICHAEL B | 1617 | §103§112DP | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18329272 | NOVEL PROCESS | ALAM, AYAAN A | 1611 | §103DP | Final Rejection | — | Pending | Jun 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSpecnova LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Michael B Pallay has the most, with 1 of Specnova LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
